Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2013742355
Up to date per 04.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2013742355
Title / Product Name
5-HT3-REZEPTORANTAGONISTEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2013742355
EP Publication Number
2875011
E-Number
962244
Language
EN
PCT Number
US13050746
Publication Date
27.05.2015 A
10.01.2018 B1
Registration Date
10.01.2018
AT Publication Date
15.01.2018
Application Date
16.07.2013
Registration Number
-
Priorities
17.07.2012
US
201261672709 P
01.10.2012
US
201261708521 P
IPC
C07D 221/22 20060101AFI20170303BHEP
Maximum Duration of Protection
16.07.2033
Owner
Takeda Pharmaceutical Company Limited
1-1, Doshomachi-4-chome, Chuo-ku, Osaka-shi,
Osaka 541-0045
JP
Representative
Representative
Häupl & Ellmeyer KG Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
HITCHCOCK, Stephen
10410 Science Center Drive
San Diego, California 92121
US
MONENSCHEIN, Holger
10410 Science Center Drive
San Diego, California 92121
US
REICHARD, Holly
10410 Science Center Drive
San Diego, California 92121
US
SUN, Huikai
10410 Science Center Drive
San Diego, California 92121
US
KIKUCHI, Shota
10410 Science Center Drive
San Diego, California 92121
US
MACKLIN, Todd
10410 Science Center Drive
San Diego, California 92121
US
HOPKINS, Maria
10410 Science Center Drive
San Diego, California 92121
US
Information about Fees
Click here to load the fees